Bolt Biotherapeutics Inc.
BOLT | NASDAQ
$3.59
+$0.03 (+0.84%)
At close: Sep 21, 2026, 4:00 PM ET
$3.59
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:10 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 7.7M | 7.69M | 7.88M | 5.73M | 1.26M | 231K |
Cost of Revenue | 1.49M | n/a | 61.54M | 73.12M | 75.66M | 40.36M |
Gross Profit | 6.2M | 7.69M | -53.67M | -67.39M | -74.4M | -40.13M |
Operating Income | -34.63M | -73.05M | -76.2M | -90.32M | -92.79M | -49.18M |
Interest Income | 2.5M | 5.26M | 7M | 2.22M | 281K | 199K |
Pretax Income | -33.38M | -63.12M | -69.2M | -88.1M | -98.59M | -60.73M |
Net Income | -33.38M | -63.12M | -69.2M | -88.1M | -98.59M | -60.73M |
Selling & General & Admin | 13.8M | 18.46M | 22.53M | 22.93M | 18.39M | 9.06M |
Research & Development | 28.53M | 57.47M | 61.54M | 73.12M | 75.66M | 40.36M |
Other Expenses | -1.49M | 4.81M | -61.54M | -73.12M | -75.66M | -40.36M |
Operating Expenses | 40.84M | 80.74M | 22.53M | 22.93M | 18.39M | 9.06M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 42.33M | 80.74M | 84.07M | 96.05M | 94.05M | 49.41M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.87M | 1.91M | 1.89M | 1.87M | 1.87M | 1.81M |
Shares Outstanding (Diluted) | 1.87M | 1.91M | 1.89M | 1.87M | 1.87M | 1.81M |
EPS (Basic) | -17.85 | -1.65 | -1.83 | -2.30 | -2.79 | -1.99 |
EPS (Diluted) | -17.85 | -1.65 | -1.83 | -2.30 | -2.79 | -1.99 |
EBITDA | -31.89M | -66.46M | -67.34M | -86.43M | -97.4M | -48.57M |
EBIT | -33.38M | -68.24M | -69.2M | -88.1M | -98.59M | -49.18M |
Depreciation & Amortization | 1.49M | 1.78M | 1.85M | 1.67M | 1.19M | 611K |
Add to Watchlist
Select watchlists to add or remove BOLT